Yahoo Web Search

  1. Ad
    related to Eli Lilly and Company
  1. Yahoo Finance Results

  2. Upgraded from Neutral on July 27th 2018 Summary This company ranked positively compared to the Healthcare sector despite only 2 positive IHS Markit Categories Perception of the company ...

  3. Here's What's Going On at Eli Lilly and GlaxoSmithKline

    Motley Fool via Yahoo FinanceAug 01 21:24 PM

    Fool contributor Todd Campbell to explain how diabetes treatments are driving growth at Eli Lilly & Co. (NYSE: LLY) and why investors ought to pay attention to Lilly< ...

    105.55+1.19 (+1.14%)

    at Fri, Aug 17, 2018, 15:02PM EST - U.S. Markets closed

    After Hours 105.54 -0.01 (-0.01%)

    Nasdaq Real Time Price

    • Open 104.43
    • High 105.92
    • Low 103.96
    • Prev. Close 104.36
    • 52 Wk. High 105.92
    • 52 Wk. Low 73.69
    • P/E N/A
    • Mkt. Cap 107.57B
  4. "This Shipping Play Looks Like a Winner, and Yields Nearly 7%" by Nicholas Jasinski points out that buying shares of a shipping-container company at the start of an international ...

  5. Is Eli Lilly (LLY) a Great Dividend Play?

    Zacks via Yahoo FinanceAug 08 13:15 PM

    A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend ...

  6. Diabetes Superpower Eli Lilly's Results

    Motley Fool via Yahoo FinanceAug 02 21:24 PM

    Fool contributor Todd Campbell discuss the impact its diabetes drugs had on its second-quarter 2018 results, plus the company's decision to exit the animal health business. Kristine Harjes ...

  7. Eli Lilly & Co.’s animal-health unit has filed for a U.S. initial public offering, formalizing the next step in the parent company’s move to focus completely on drugs for ...

  8. Eli Lilly Stock History

    Motley Fool via Yahoo FinanceAug 10 12:08 PM

    Eli Lilly and Company (NYSE: LLY) generates over 40% of its sales from diabetes medications, including insulin, and its sales could grow significantly over ...

  9. Although Radius Health reported a narrower-than-expected loss in the last quarter, the company’s track record is dismal. Radius Health’s shares have lost 27.8% in the year so far compared ...

  10. Incyte (INCY) Earnings Miss, Revenues Beat Estimates in Q2

    Zacks via Yahoo FinanceJul 31 20:00 PM

    The company reported a net income of 26 cents in the second quarter of 2018, which missed the Zacks Consensus Estimate of 30 cents and was a penny down from 27 cents reported in ...

  11. Sanofi's (SNY) Q2 Earnings Surpass Estimates, Sales Miss

    Zacks via Yahoo FinanceJul 31 13:42 PM

    Sanofi Genzyme/Specialty Care GBU sales (including emerging markets) increased 29.5% to €2.07 billion, driven by contribution from new immunology drugs — Dupixent and Kevzara — along ...

  1. Ad
    related to Eli Lilly and Company